Kosmos AI drafts IND filings in 4.2 hours vs 100 expert hours, cutting a drug program by 3 months
CatAstro_Piyush · x · 2026-10-01
Edison Scientific's Kosmos products (Clinical Protocol Design and Regulatory Authoring) have been supporting Population Health Partners' IND preparation since June, with concrete results:
- A first acceptable draft of the Nonclinical Overview produced in 4.2 hours versus 100 hours of expert time
- Flagged an error that roughly fifteen human reviewers missed
- Authored 70% of the text in a Pre-IND Briefing document
The retweeter notes this translates into a 3-month reduction in a real drug program — a concrete, quantified counterexample to hand-wavy claims that AI will accelerate drug discovery.
More from Apps
- ChatGPT's dot assistant in Dev Early Access: spotted a cancelled train and saved a user's day — gabrielchua · 2026-10-01
- MeetTwins sends an AI avatar to your Google Meet calls so you don't have to — CackleRooster · 2026-10-01
- New AI phone agent makes calls for you from inside Claude Code and Codex — damnGruz · 2026-10-01
- Ex-games founder prototypes a game with AI: don't outsource the creative process — trq212 · 2026-10-01
- Meta disputes claim its Muse agent read private messages without permission — TechCrunch AI · 2026-10-01
- Topos Bio launches Topos-2 and Topos-Bind to model disordered 'undruggable' proteins — charles_irl · 2026-10-01